Compare Freeport-McMoRan Inc (FCX) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Freeport-McMoRan Inc vs ImmunityBio Inc. Common Stock — how do they compare? Freeport-McMoRan Inc trades at $72.28 (market cap $103.19B), while ImmunityBio Inc. Common Stock trades at $10.02 (market cap $10.33B). The key difference: Freeport-McMoRan Inc is far larger — about 10× ImmunityBio Inc. Common Stock's market cap, and Freeport-McMoRan Inc pays a 0.83% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Freeport-McMoRan Inc for 69 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| FCX | IBRX | |
|---|---|---|
Market Cap | $103.19B | $10.33B |
Volume | 11,744,911 | 11,745,198 |
Sector | Basic Materials | Health |
52-Week High | $79.91 | $11.55 |
52-Week Low | $38.65 | $1.98 |
Typical Hold Time | 69 Days | 0 Days |
Enterprise Value | $109.47B | $10.79B |
Dividend Yield | 0.83% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FCX trades at $71.13, down 1.98% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $72.27. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Strong operating cash flow of $5.61 billion in 2025 supports ongoing expansion projects amid favorable copper demand trends.
The outlook for FCX is positive, driven by robust copper demand from AI and data center growth, but risks include rising production costs and a legal investigation. Wall Street sentiment is bullish with 61% buy ratings, though the stock faces near-term resistance at $72.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Freeport-McMoRan Inc
Freeport-McMoRan Inc is an international mining company. It operates geographically diverse assets with proven and probable mineral reserves of copper, gold and molybdenum. The company's portfolio of assets includes the Grasberg minerals district in Indonesia
Read more on FCX →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
